FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to cardiology and angiology; it can be applied for angiopathy correction in metabolic syndrome patients. The method consists in four-month course administration that includes low-calorie diet, graduated exercise, and drug therapy: 30 mg pioglitazon daily, 50 mg lozartan daily at appointed time.
EFFECT: allows correction of angiopathy manifestations in metabolic syndrome patients, owing to anti-thrombosis activity of blood vessels.
1 ex, 1 tbl, 1 dwg
Authors
Dates
2008-11-27—Published
2007-07-09—Filed